Defect Engineering‐Driven Electron Spin Polarization and Charge Transfer in MOFs for Enhanced Sonocatalytic Therapy
Sonocatalytic therapy (SCT) is a non-invasive tumor treatment modality that utilizes ultrasound (US)- activated sonocatalysts to generate reactive oxygen species (ROS), whose production critically dependent on the electronic structural properties of the catalytic sites. However, the spin state, which is a pivotal descriptor of electronic properties, remains underappreciated in SCT. Herein, a Ti-doped zirconium-based MOF (Ti-UiO-66, denoted as UTN) with ligand-deficient defects is constructed for SCT, revealing the important role of the electronic spin state in modulating intrinsic catalytic activity. The defect-driven sonocatalytic mechanism is elucidated as follows: 1) structural defects alleviate the limitations of ligand-metal charge transfer, achieving a 2.1-fold enhancement in charge transfer efficiency; 2) spin polarization at Ti active sites reconfigures the d-orbital electron distribution, thereby increasing the density of spin-polarized electronic states near the Fermi level. Furthermore, Ti 3d-O 2p orbital hybridization lowers the adsorption energies of H<sub>2</sub>O and O<sub>2</sub> by 2.5-fold and 1.6-fold, respectively, thereby facilitating interfacial redox reactions and leading to enhanced ROS generation. Notably, UTN combined with US achieves 86.07% tumor inhibition efficiency. This work establishes novel insights into defect engineering, spin-state modulation, and surface interfacial adsorption in SCT, providing a theoretical paradigm framework for designing of high-performance sonocatalysts.
Authors
- Zezhong Huang
- Dandan Hou
- Zhijun Huang (ORCID: https://orcid.org/0000-0003-1539-5212)
- Xueting Pan (ORCID: https://orcid.org/0000-0001-7280-9050)
- Yun Sun (ORCID: https://orcid.org/0000-0002-2652-3040)
- Juan Guo (ORCID: https://orcid.org/0000-0001-7960-5237)
- Jingqian Deng (ORCID: https://orcid.org/0000-0002-9522-2604)
- Xican Xu
- Chaohui Wang (ORCID: https://orcid.org/0000-0001-8592-4920)
- Qingyuan Wu (ORCID: https://orcid.org/0000-0002-8103-0062)
- Huiyu Liu (ORCID: https://orcid.org/0000-0003-4465-8501)
Institutions
- Beijing National Laboratory for Molecular Sciences (CN)
- Beijing Chemical Industry Research Institute (China) (CN)
- Beijing University of Chemical Technology (CN)
Publication Details
- Journal
- Advanced Materials
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1002/adma.202506721
- Citations
- 4
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 2.70
Funders
- National Natural Science Foundation of China
- Beijing University of Chemical Technology
- Fundamental Research Funds for the Central Universities